Liminal BioSciences Inc. PFSCF

Primary Symbol: LMNL

Healthcare Biotechnology

Liminal BioSciences is a biopharmaceutical company focused on the discovery and development of novel, small molecule drug candidates for the treatment of patients suffering from fibrotic or inflammatory diseases that have a high unmet medical need. Liminal BioSciences operates on an integrated basis from our talent hubs in Laval, Quebec, Canada, and Cambridge, UK. Our common shares are listed for trading on the Nasdaq Global Market.

NDAQ:LMNL - Post by User

Liminal BioSciences Inc. > Ryplazim FDA decision in 4 days!

<< Previous

Bullboard Posts

Next >>

Comment by GunnerGon Jun 02, 2021 3:57pm

46 Views

Post# 33312610

RE:RE:Ryplazim FDA decision in 4 days!

Stups was predicting 2x 3x on agreement signing and it was a fart in a wind storm. Nothing came of it because they gave away the farm.

Nothing new here.

Newcamo wrote:
second try, deal with kedrion made, i think we'll get it this time! the deal is worth about present market cap +-100M$... the sp will go up several fold from here, how many fold? x3 seems possible for me... if not before after for sur.......

StockReddy wrote:

There will be a huge prerun before the NEWS! I am guessing around $12.

Hold tight

IMHO